Cargando…

Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera

BACKGROUND: The big challenge in any anti-tumor therapeutic approach is represented by the development of drugs selectively acting on the target with limited side effects, that exploit the unique characteristics of malignant cells. The urokinase (urokinase-type plasminogen activator, uPA) and its re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Errico Provenzano, Alfredo, Posteri, Riccardo, Giansanti, Francesco, Angelucci, Francesco, Flavell, Sopsamorn U., Flavell, David J., Fabbrini, Maria Serena, Porro, Danilo, Ippoliti, Rodolfo, Ceriotti, Aldo, Branduardi, Paola, Vago, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109808/ https://www.ncbi.nlm.nih.gov/pubmed/27842546 http://dx.doi.org/10.1186/s12934-016-0589-1

Ejemplares similares

The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP
por: Zuppone, S., et al.
Publicado: (2020)

Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins
por: Giansanti, Francesco, et al.
Publicado: (2018)

Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems
por: Della Cristina, Pietro, et al.
Publicado: (2015)

The Effect of Small Molecule Pharmacological Agents on the Triterpenoid Saponin Induced Endolysosomal Escape of Saporin and a Saporin-Based Immunotoxin in Target Human Lymphoma Cells
por: Wensley, Harrison J., et al.
Publicado: (2021)

The Role of Cholesterol on Triterpenoid Saponin-Induced Endolysosomal Escape of a Saporin-Based Immunotoxin
por: Smith, Wendy S., et al.
Publicado: (2020)

Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents
por: Smith, Wendy S., et al.
Publicado: (2019)

Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
por: Flavell, D. J., et al.
Publicado: (1997)

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
por: Flavell, D. J., et al.
Publicado: (1995)

Fourier transform infrared spectroscopy as a method to study lipid accumulation in oleaginous yeasts
por: Ami, Diletta, et al.
Publicado: (2014)

Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience
por: Flavell, David J., et al.
Publicado: (2022)

Assessing an effective feeding strategy to optimize crude glycerol utilization as sustainable carbon source for lipid accumulation in oleaginous yeasts
por: Signori, Lorenzo, et al.
Publicado: (2016)

Characteristics and performance of a bispecific F (ab'gamma)2 antibody for delivering saporin to a CD7+ human acute T-cell leukaemia cell line.
por: Flavell, D. J., et al.
Publicado: (1991)

Effectiveness of combinations of bispecific antibodies for delivering saporin to human acute T-cell lymphoblastic leukaemia cell lines via CD7 and CD38 as cellular target molecules.
por: Flavell, D. J., et al.
Publicado: (1992)

From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?
por: Ardini, Matteo, et al.
Publicado: (2022)

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin
por: Flavell, D J, et al.
Publicado: (2001)

A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer
por: Zuppone, Stefania, et al.
Publicado: (2022)

Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice.
por: Morland, B. J., et al.
Publicado: (1994)

The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-Cell Leukaemia
por: Flavell, David J., et al.
Publicado: (2019)

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
por: Capone, Emily, et al.
Publicado: (2017)

A Flow Cytometric Method to Quantify the Endosomal Escape of a Protein Toxin to the Cytosol of Target Cells
por: Wensley, Harrison J., et al.
Publicado: (2019)

New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents
por: Bortolotti, Massimo, et al.
Publicado: (2023)

Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
por: di Leandro, Luana, et al.
Publicado: (2021)

Bio-Tailored Sensing at the Nanoscale: Biochemical Aspects and Applications
por: Fata, Francesca, et al.
Publicado: (2023)

Analysis of the Sequence Preference of Saporin by Deep Sequencing
por: Hauf, Samuel, et al.
Publicado: (2022)

Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression
por: Zuppone, Stefania, et al.
Publicado: (2019)

Taking Advantage of the Morpheein Behavior of Peroxiredoxin in Bionanotechnology
por: Ardini, Matteo, et al.
Publicado: (2021)

Saporin-S6: A Useful Tool in Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2013)

Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins
por: Ancheta, Leonardo R., et al.
Publicado: (2023)

Antibody-Drug Conjugates: The New Frontier of Chemotherapy
por: Ponziani, Sara, et al.
Publicado: (2020)

Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.
por: Tazzari, P. L., et al.
Publicado: (1993)

Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions)
por: Fabbrini, Maria Serena, et al.
Publicado: (2017)

Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2011)

The Nutraceutical Properties of Ovotransferrin and Its Potential Utilization as a Functional Food
por: Giansanti, Francesco, et al.
Publicado: (2015)

Yeast cell factory: fishing for the best one or engineering it?
por: Porro, Danilo, et al.
Publicado: (2009)

High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
por: Bortolotti, Massimo, et al.
Publicado: (2016)

Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
por: Castiello, Maria Carmina, et al.
Publicado: (2020)

Clathrin and LRP-1-Independent Constitutive Endocytosis and Recycling of uPAR
por: Cortese, Katia, et al.
Publicado: (2008)

Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities
por: Leitman, Ellen M., et al.
Publicado: (2017)

Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience
por: Bolshakov, Alexey P., et al.
Publicado: (2020)

Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells
por: Salvioni, Lucia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e834l6dervshg7e22llt44ekag